Chemotherapeutic Drugs Sensitize Human Renal Cell Carcinoma Cells to ABT-737 by a Mechanism Involving the Noxa-Dependent Inactivation of McL-1 or A1

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-9-164
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The BH3 Mimetic Drug ABT-737 Induces Apoptosis and Acts Synergistically With Chemotherapeutic Drugs in Thyroid Carcinoma Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2016English

Glycolysis Inhibition Targets McL-1 to Restore Sensitivity of Lymphoma Cells to ABT-737-induced Apoptosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

McL-1 Down-Regulation Potentiates ABT-737 Lethality by Cooperatively Inducing Bak Activation and Bax Translocation

Cancer Research
Cancer ResearchOncology
2007English

Monosaccharide Digitoxin Derivative Sensitize Human Non-Small Cell Lung Cancer Cells to Anoikis Through McL-1 Proteasomal Degradation

Biochemical Pharmacology
BiochemistryPharmacology
2014English

ABT-737 Induces Apoptosis in Mantle Cell Lymphoma Cells With a BCL-2high/McL-1low Profile and Synergizes With Other Antineoplastic Agents

Clinical Cancer Research
Cancer ResearchOncology
2011English

1 H NMR Metabolomics Analysis of Renal Cell Carcinoma Cells: Effect of VHL Inactivation on Metabolism

International Journal of Cancer
Cancer ResearchOncology
2016English

Synergistic BCL-2 Inhibition by ABT-737 and Cyclosporine A

Apoptosis : an international journal on programmed cell death
Cell BiologyPharmacologyBiochemistryClinical BiochemistryCancer ResearchPharmaceutical Science
2012English

Norcantharidin Enhances ABT-263-mediated Anticancer Activity in Neuroblastoma Cells by Upregulation of Noxa

Oncology Reports
MedicineCancer ResearchOncology
2014English

Interleukin 15–mediated Survival of Natural Killer Cells Is Determined by Interactions Among Bim, Noxa and McL-1

Nature Immunology
AllergyImmunology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy